CellType

CellType YC 申请

Winter 2026Active

CellType 在 Winter 2026 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。

YC 批次
Winter 2026
行业
HealthcareDrug Discovery and Delivery
团队规模
2
状态
Active
已发布
2026

创始人

  • David van Dijk
    David van DijkCo-Founder & CEO
  • Ivan Vrkic
    Ivan VrkicCo-Founder

CellType 做什么

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.

CellType 的 YC 申请,重建版

Y Combinator 申请

CellType,Winter 2026 期。来自公开数据的真实申请问题解答。

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

CellType

Describe what your company does in 50 characters or less.

The agentic drug company. We simulate human biology.

What is your company going to make? Please describe your product and what it does or will do.

We are building AI agents that run the entire drug discovery pipeline on top of biological foundation models that simulate human biology. Our platform can predict how drugs interact with biological systems, enabling us to discover new treatments faster and more reliably than traditional methods. We've already found and validated a new cancer treatment signal using this tech.

Where do you live now, and where would the company be based after YC?

We live and work in New York City, and after YC, CellType will remain based here.

Explain your decision regarding location.

New York City has the biotech ecosystem and pharma partners we need close by. We can recruit scientists and engineers here and maintain strong relationships with top pharma companies already collaborating with us.

21 更多回答 在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。

常见问题解答

这是 CellType 的真实 YC 申请吗?

不是。Y Combinator 对提交的申请保密。这是重建版:使用 CellType 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 CellType 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。

CellType 是哪个 YC 批次的?

CellType 是 Y Combinator Winter 2026 批次的成员。

谁创立了 CellType?

CellType 由 David van Dijk, Ivan Vrkic 创立。

CellType 做什么?

The agentic drug company. We simulate human biology.

如何阅读完整的重建申请?

创建免费的 Round Funded 账户。YC Insights 中包含 CellType 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。

更多 YC 初创公司,例如 CellType